×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Clinical: DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulat
clinical
3,187 words
KG: DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulation for AD
2026-03-28
kind:clinical-trial
section:clinical-trials
state:published
disease:alzheimers
topic:neurostimulation
Contents
DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulation for AD
Knowledge Graph
Related Hypotheses (21)
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
APOE Isoform Conversion Therapy
Score: 0.44
Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.69
Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53
Heterogeneous astrocyte activation states differentially imp
Score: 0.52
Astrocyte-Mediated Microglial Memory Erasure
Score: 0.46
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Blood-Brain Barrier SPM Shuttle System
Score: 0.55
Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52
Vocal Cord Neuroplasticity Stimulation
Score: 0.50
Lysosomal Calcium Channel Modulation Therapy
Score: 0.49
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
FOXO3-Longevity Pathway Epigenetic Reprogramming
Score: 0.39
Show 16 more
Related Analyses (19)
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · failed
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed
Show 14 more
Related Experiments (14)
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
Levodopa-Induced Dyskinesias Mechanism — Experiment Design
validation · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40
iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40
Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40
tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.40
Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
Multi-omics analysis of myricanol effects on gene expression
exploratory · proposed · Score: 0.88
Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40
Show 9 more
See Also (15)
vitamin-d-therapy-neurodegeneration
therapeutic · Pages share 4 hypotheses
TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses
Trace Amine-Associated Receptor (TAAR) Modulator Therap
therapeutic · Pages share 4 hypotheses
SYK Kinase Inhibitor Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses
STING Inhibitor Therapy in Neurodegeneration
therapeutic · Pages share 4 hypotheses
Specialized Pro-Resolving Mediator (SPM) Therapy for Ne
therapeutic · Pages share 4 hypotheses
Specialized Pro-Resolving Mediator (SPM) Therapies for
therapeutic · Pages share 4 hypotheses
Somatostatin Receptor Modulator Therapy in Neurodegener
therapeutic · Pages share 4 hypotheses
Section 152: Advanced Robotics and Assistive Devices in
therapeutic · Pages share 4 hypotheses
Section 147: Telehealth and Remote Monitoring in CBS/PS
therapeutic · Pages share 4 hypotheses
S100 Protein (S100A8/A9/A12) Modulator Therapy for Neur
therapeutic · Pages share 4 hypotheses
RNA Targeting Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses
Progranulin Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses
nt-3-therapy-neurodegeneration
therapeutic · Pages share 4 hypotheses
Neurotensin Receptor Modulator Therapy for Neurodegener
therapeutic · Pages share 4 hypotheses
Show 10 more
Knowledge Graph (3 edges)
DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulation for AD
references
APOE
DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulation for AD
references
GFAP
DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulation for AD
references
BDNF